Glaxo Forecasts 2013 Earnings, Sales Growth

GlaxoSmithKline Plc, the U.K.’s largest drugmaker, said sales and profit will rise this year as the company awaits regulators’ approval of six drugs.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.